Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
11 Mars 2024 - 12:51PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934.
| | | | | | | | | | | | | | |
| | | Commission File Number | 001-40947 |
| | | | |
LianBio The Nasdaq Global Market |
| (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered) |
|
| 103 Carnegie Center Drive, Suite 309 |
| Princeton, NJ 08540 (609) 486-2308 |
| (Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices) |
|
| American Depositary Shares, each representing one ordinary share, par value $0.000017100448 per share |
| (Description of class of securities) |
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
☐ 17 CFR 240.12d2-2(a)(1)
☐ 17 CFR 240.12d2-2(a)(2)
☐ 17 CFR 240.12d2-2(a)(3)
☐ 17 CFR 240.12d2-2(a)(4)
☐ Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.1
☒ Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements of the Securities Exchange Act of 1934, LianBio certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
| | | | | | | | | | | | | | |
| March 11, 2024 | | By: /s/ Adam Stone | | Interim Chief Executive Officer |
| Date | | Name: Adam Stone | | Title |
| | | | | |
SEC 1654
(03-06) | Potential persons who are to respond to the collection of information contained in this Form are not required to respond unless the Form displays a currently valid OMB control number. |
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
LianBio (NASDAQ:LIAN)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
LianBio (NASDAQ:LIAN)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024
